June 2026
The Australia GLP-1 receptor agonist market size was valued at USD 652.07 million in 2026 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.
September 2026
The global GnRH receptor antagonists market size was evaluated at USD 2.52 billion in 2026 and is predicted to hit around USD 5.25 billion by 2035, growing at a CAGR of 8.50%.
September 2026
The global S1P receptor modulator drugs market size is estimated to hit around USD 6.96 billion by 2035 increasing from USD 3.42 billion in 2026, with a CAGR of 8.22%.
September 2026
The australia rare earth minerals market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
July 2026
The global GLP-1 market size was evaluated at USD 58.40 billion in 2025 and is predicted to hit around USD 212.73 billion by 2035, growing at a CAGR of 13.80%.
July 2026
The global GLP-1 analogues market size was evaluated at USD 66.48 billion in 2025 and is predicted to hit around USD 1,062.90 billion by 2035, growing at a CAGR of 31.94%
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global THR-β agonist market size was evaluated at USD 1.53 billion in 2025 and is predicted to hit around USD 6.58 billion by 2035, growing at a CAGR of 15.72%.
February 2026
The global obesity GLP-1 market size was evaluated at USD 8.21 billion in 2025 and is predicted to hit around USD 66.57 billion by 2035, growing at a CAGR of 23.28%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com